METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer combo trial halted after just 2 patients
Disease control TerminatedThis early-stage trial aimed to see if combining the immunotherapy drug pembrolizumab with precise radiation (SBRT) to a lung tumor is safe for people with advanced non-small-cell lung cancer that has spread. Only 2 patients were enrolled before the study was stopped. The main go…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Experimental cell therapy targets tough lung cancers
Disease control TerminatedThis early-phase study tested a personalized cell therapy (C-TIL051) for people with advanced non-small cell lung cancer that no longer responded to standard anti-PD1 drugs. Participants provided a tumor sample to grow immune cells, then received chemotherapy followed by an infus…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC